TCL Archive Survival Of Control Programs After NCI Money Runs Out Developing Into A Worrisome Issue June 1, 1975
TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive Race And Cancer: “It Would Be Wrong To Design Studies Based On Assumptions That Races Are Biologically Different,” Klausner Says June 19, 1998